Medical Devices Startups

MeMed develops host-immune response diagnostics that use machine learning to distinguish between bacterial and viral infections, with its FDA-cleared MeMed BV test delivering results in 15 minutes. Its MeMed Key immunoassay platform runs sensitive multiplexed protein measurements at the point of care to help physicians manage acute infections and reduce unnecessary antibiotic use.</parameter> <parameter name="founders">[]

3 investors

Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations. It focuses on developing genetic medicines to treat diseases with well-understood biology.

3 investors

MiCAN Technologies produces immortalized blood cells (erythroid and myeloid-lineage cells) using regenerative medicine technology, supplying research-use blood-like cells, evaluation kits, and contract testing services. Its products serve infectious disease research and the efficacy/safety evaluation of pharmaceuticals and functional materials, including a pyrogen (fever-inducing substance) alternative testing kit.

3 investors

Minze Health develops solutions for diagnosing and managing lower urinary tract symptoms (LUTS), such as those caused by benign prostatic hyperplasia (BPH) or overactive bladder (OAB). The company targets the large population of adults affected by urinary conditions in the U.S. and EU.

3 investors

Mirador discovers and develops precision medicines for immune-mediated and immuno-fibrotic diseases using a target-patient matching approach. The company targets therapeutics to improve treatment efficacy beyond current standards in immunology and fibrotic conditions.

3 investors

miraDry offers an FDA-cleared medical procedure that uses thermal energy to permanently destroy underarm sweat glands, odor glands, and hair follicles, administered by trained healthcare practitioners. The treatment targets excessive underarm sweat and odor (axillary hyperhidrosis) in patients seeking long-term reduction.

3 investors

Mironid is a drug development company building a pipeline of therapies targeting cAMP-degrading phosphodiesterase enzymes to treat Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare kidney diseases. It focuses on developing novel therapeutics for rare diseases with high unmet clinical need.

3 investors

Mitra develops a non-invasive skin diagnostics platform that combines clinical trials, skin sampling, next-generation sequencing, and data science to guide the design of age-rejuvenating skincare compounds. The company applies genomics to skin health and precision dermatological therapies.

3 investors

MiWendo develops an electromagnetic accessory for colonoscopes that automates polyp detection and differentiates benign from malignant tissues to improve early colorectal cancer diagnosis. The device is designed for use in gastroenterology and oncology clinical practices.

3 investors

Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment. It serves stroke patients and the clinicians who treat them in the medical device industry.

3 investors

Modality.AI develops an AI-based multimodal assessment platform that uses app-collected data to help diagnose and monitor neurodegenerative diseases such as ALS. It serves clinicians and patients, aiming to reduce reliance on in-clinic evaluations for conditions like ALS.

3 investors

Moichor is an animal diagnostics laboratory providing automated blood count and cytology testing for veterinarians across the United States. The company uses artificial intelligence and computer vision to deliver species-specific pathology results through both send-in laboratory services and an in-clinic hematology device.

3 investors

mOm develops the mOm Essential, a neonatal incubator that warms newborns to normal body temperature to prevent hypothermia and avoidable NICU admissions. The device is used by healthcare providers across maternity, delivery, transitional care, theatres, NICU, and humanitarian settings.

3 investors

Monitra Health provides hospital-grade cardiac monitoring devices and services, including Holter monitors, external loop recorders, and mobile cardiac telemetry solutions that record and analyze heart activity in ambulatory settings with AI-assisted clinical review and reporting.

3 investors

Mosanna is a pharmaceutical company developing a non-invasive nasal spray therapy for obstructive sleep apnea (OSA) that reactivates the body's natural airway reflex to keep the upper airway open during sleep. Its lead candidate, MOS-118, is a small molecule delivered before bedtime that stimulates upper airway dilator muscles to reduce apnea and hypopnea episodes.

3 investors

Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression. The company builds implantable neurotechnology for patients with mental illness and is based in Houston, Texas.

3 investors

MOWOOT is a non-invasive medical device that delivers Intermittent Colonic Exoperistalsis (ICE), applying gentle sequential abdominal pressure inspired by clinical abdominal massage to support bowel movement in people with chronic constipation. It serves patients with reduced natural peristalsis as well as healthcare professionals, and its approach has been evaluated in multiple clinical studies.

3 investors

MuReva Phototherapy develops oral phototherapy devices intended to reduce dose-limiting side effects, such as oral mucositis, in cancer patients undergoing radiation and chemotherapy. Spun off from fiber-optic lighting company Lumitex, its light-transmission technology is being evaluated in a U.S. multicenter clinical trial and is not yet commercially available.

3 investors

Myoridge develops serum-free cell culture media and optimization services for cell cultivation and regenerative medicine applications. The company provides media formulations, consulting, and in vitro model development support to organizations conducting biotechnology research and cell therapy product development.

3 investors

Myricx is a biotech company developing a new class of payloads for antibody drug conjugates (ADCs) based on inhibitors of N-myristoyltransferase (NMT) enzymes, aimed at treating cancer. Its pipeline targets solid tumour associated antigens in oncology.

3 investors

Nalu Bio develops an AI-powered drug discovery platform targeting the endocannabinoid system to create therapeutics for inflammatory, immune, and metabolic diseases. The company designs novel, non-addictive ECS-based solutions for patients with conditions like chronic pain, sleep disorders, and endometriosis.

3 investors

NanoCellect develops microfluidic-based cell sorters that operate at low pressure to sort cells with high viability and reduced shear stress, aimed at scientists and researchers. Its products use disposable, sterile microfluidic cartridges for applications such as single-cell sorting and stem cell research.

3 investors

Nanochon develops Chondrograft, a 3D-printed, off-the-shelf orthopedic implant that is press-fit into damaged knee cartilage to support the body's natural tissue healing. It targets "pre-replacement" patients with focal cartilage defects who need more than temporary relief but are not yet candidates for joint replacement.

3 investors

Nautilus develops proteomics technology to unlock the complexity of the human proteome for biomedical research and diagnostics. The company targets pharmaceutical, biotechnology, academic, clinical, and government sectors with advanced protein quantification and analysis platforms.

3 investors